Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hayley Suen

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Neoplasia (New York, N.Y.)|January 26, 2016
Isolation of Human CD138(+) Microparticles from the Plasma of Patients with Multiple MyelomaSabna Rajeev Krishnan, Frederick Luk, Ross D Brown, et al.
Oncoimmunology|December 25, 2012
Trogocytosis generates acquired regulatory T cells adding further complexity to the dysfunctional immune response in multiple myelomaRoss Brown, Hayley Suen, James Favaloro, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 8, 2016
The T Cell in MyelomaDouglas Joshua, Hayley Suen, Ross Brown, et al.
Blood Cancer Journal|March 15, 2020
A liquid biopsy to detect multidrug resistance and disease burden in multiple myelomaSabna Rajeev Krishnan, Gabriele De Rubis, Hayley Suen, et al.
Leukemia & Lymphoma|July 20, 2013
Myeloma skews regulatory T and pro-inflammatory T helper 17 cell balance in favor of a suppressive stateJames Favaloro, Ross Brown, Esther Aklilu, et al.
Blood|June 19, 2012
CD86+ or HLA-G+ can be transferred via trogocytosis from myeloma cells to T cells and are associated with poor prognosisRoss Brown, Karieshma Kabani, James Favaloro, et al.
Leukemia & Lymphoma|March 15, 2014
Myeloid derived suppressor cells are numerically, functionally and phenotypically different in patients with multiple myelomaJames Favaloro, Tulita Liyadipitiya, Ross Brown, et al.
Immunology and Cell Biology|January 22, 2016
A CD2 high-expressing stress-resistant human plasmacytoid dendritic-cell subsetChristian Bryant, Phillip D Fromm, Fiona Kupresanin, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Neoplasia (New York, N.Y.)|January 26, 2016
Isolation of Human CD138(+) Microparticles from the Plasma of Patients with Multiple MyelomaSabna Rajeev Krishnan, Frederick Luk, Ross D Brown, et al.
Oncoimmunology|December 25, 2012
Trogocytosis generates acquired regulatory T cells adding further complexity to the dysfunctional immune response in multiple myelomaRoss Brown, Hayley Suen, James Favaloro, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 8, 2016
The T Cell in MyelomaDouglas Joshua, Hayley Suen, Ross Brown, et al.
Blood Cancer Journal|March 15, 2020
A liquid biopsy to detect multidrug resistance and disease burden in multiple myelomaSabna Rajeev Krishnan, Gabriele De Rubis, Hayley Suen, et al.
Leukemia & Lymphoma|July 20, 2013
Myeloma skews regulatory T and pro-inflammatory T helper 17 cell balance in favor of a suppressive stateJames Favaloro, Ross Brown, Esther Aklilu, et al.
Blood|June 19, 2012
CD86+ or HLA-G+ can be transferred via trogocytosis from myeloma cells to T cells and are associated with poor prognosisRoss Brown, Karieshma Kabani, James Favaloro, et al.
Leukemia & Lymphoma|March 15, 2014
Myeloid derived suppressor cells are numerically, functionally and phenotypically different in patients with multiple myelomaJames Favaloro, Tulita Liyadipitiya, Ross Brown, et al.
Immunology and Cell Biology|January 22, 2016
A CD2 high-expressing stress-resistant human plasmacytoid dendritic-cell subsetChristian Bryant, Phillip D Fromm, Fiona Kupresanin, et al.
Pageof 1